(Woonsocket, United States) – CVS Health plans to separate its approximately 9,000 retail pharmacies from its insurance and pharmacy-services businesses, dismantling a corporate structure that brought drugstores, prescription benefits and health coverage under one roof.

The company confirmed the plan November 4 after a strategic review by its board. It expects to complete the separation into two publicly traded companies in the first half of 2028. The announcement establishes the proposed structure and timetable; the breakup has not been completed.

A new company called CVS Pharmacy would contain the retail drugstores, mail-order pharmacy operations, MinuteClinic services and the Health100 technology-services business. Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health would remain together in a health-care solutions company, provisionally retaining the CVS Health name.

The decision marks a reversal of the expansion strategy exemplified by CVS’s 2018 merger with Aetna. The New York Times, in reporting published by GV Wire, described the planned breakup as an unwinding of the largest U.S. health-care conglomerate. CVS generated more than US$400 billion in revenue last year, the newspaper reported.

The move comes amid scrutiny of companies that combine insurance, prescription-benefit management and pharmacy ownership. The Times reported that Arkansas and Tennessee have passed laws aimed at preventing companies from both managing prescription benefits and operating retail and mail-order pharmacies. Critics contend that such combinations create conflicts of interest and can steer patients toward affiliated businesses; those criticisms are not findings about the effects of this proposed separation.

CVS says customers should continue receiving medicines, care and benefits without interruption during the transition. Existing shareholders would receive shares in both companies when the transaction is completed.

Completion remains conditional on final board approval, an effective U.S. securities registration statement and confirmation of the intended U.S. tax treatment. In its November 4 regulatory filing, CVS warned that the separation could take longer or cost more than expected, disrupt operations or fail to deliver its anticipated benefits.

For now, the announcement changes CVS’s corporate direction rather than its day-to-day service arrangements. The company says it will continue operating as it does today until the separation is finished.

Accompanying image: editorial illustration.

Sources